A pyrrole-biphenyl derivative compound, a preparation method thereof and application thereof in pharmacy

By developing pyrrolobenzyl derivatives, the shortcomings of existing SGLT-2 inhibitors in terms of specificity and safety in the treatment of tumors and non-alcoholic liver disease have been addressed, achieving highly efficient SGLT-2 inhibition and broad drug application, especially providing a new treatment strategy in the field of non-alcoholic liver disease.

CN120574217BActive Publication Date: 2026-06-09WUHAN DONGHU UNIV
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202510709332.5
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2025-05-29
Publication Date
2026-06-09
Estimated Expiration
2045-05-29

AI Technical Summary

Technical Problem

Existing SGLT-2 inhibitors have insufficient specificity, efficacy, and safety in the treatment of cancer and non-alcoholic liver disease, and the optimal usage regimen and combination therapy strategy are not yet clear.

Method used

To develop a pyrrolobenzene derivative compound that competitively occupies the substrate binding site or binds to the allosteric site of SGLT-2 by mimicking the glucose conformation, thereby blocking glucose transport function and inhibiting sodium-glucose cotransport activity, and to design it into various drug formulations to enhance targeting and metabolic stability.

Benefits of technology

This compound exhibits highly potent SGLT-2 inhibitory activity with an IC50 value ranging from 15 to 105 nM. It possesses favorable pharmaceutical properties and safety profile, making it suitable for various drug formulations, particularly tablets, capsules, and injections. It is applicable to the treatment of a variety of diseases related to SGLT-2 activity or expression levels, and shows great therapeutic potential, especially in the field of non-alcoholic liver disease.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN120574217B_ABST
    Figure CN120574217B_ABST
Patent Text Reader

Abstract

This invention discloses a pyrrolobenzene derivative compound, its preparation method, and its pharmaceutical application, belonging to the field of chemical pharmaceutical raw materials and formulation manufacturing technology. The compound has the structure shown. This compound specifically binds to the SGLT-2 protein through a pyrrolobenzene conjugated system, inhibiting its glucose transport function and affecting the IC50 of SGLT-2. 50 Values ​​range from 15 to 105 nM. Suitable for preparing drugs to treat non-alcoholic liver disease, solid tumors, hematological malignancies, and autoimmune diseases, especially effective against abnormal glucose and lipid metabolism in hepatocytes and energy deprivation in tumor cells. The compound possesses enhanced metabolic stability due to its deuterated group and can be formulated into tablets, capsules, injections, and other dosage forms.
Need to check novelty before this filing date? Find Prior Art